French Law Tackles Biologic Originator Tactics

Measures Form Part Of France’s Social Security Bill For 2020

France is seeking to tackle the originator tactic of using low prices for biologic brands in hospitals to snare patients and keep them on the same product once they transition to outpatient care, where prices are much higher.

Euro_Mouse_Trap
Originators are seeking to snare patients with low hospital prices • Source: Shutterstock

More from Regulation

More from Policy & Regulation